Skip to main content

GSK says exploring all options to make COVID-19 antibody drug Sotrovimab available in India quickly

GSK says exploring all options to make COVID-19 antibody drug Sotrovimab available in India quickly Treatment with Sotrovimab resulted in an 85 percent reduction in the risk of hospitalisation or death in high-risk adult COVID-19 outpatients compared to placebo, based on interim results from Phase 3 COMET-ICE trial.

from Moneycontrol Business News https://ift.tt/3oSe3J0
Labels:

Comments

Post a Comment

Popular posts from this blog

List of tax defaulters to be published from tomorrow: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yU0Uch
Post a Comment
Read more

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Post a Comment
Read more

List of tax defaulters to be published from Friday: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yToJRc
Post a Comment
Read more